<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="335043">
  <stage>Registered</stage>
  <submitdate>18/01/2010</submitdate>
  <approvaldate>10/02/2010</approvaldate>
  <actrnumber>ACTRN12610000137099</actrnumber>
  <trial_identification>
    <studytitle>Retrospective analysis of patient outcomes following surgical placement of the Swedish Adjustable Gastric Band-C (SAGB-VC) for the treatment of morbid obesity</studytitle>
    <scientifictitle>Retrospective analysis of weight loss following surgical placement of the Swedish Adjustable Gastric Band-C (SAGB-VC) for the treatment of morbid obesity</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Obesity</healthcondition>
    <conditioncode>
      <conditioncode1>Diet and nutrition</conditioncode1>
      <conditioncode2>Obesity</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>This is a retrospective audit of existing data in which we wish to analyse the efficacy and safety of the Swedish Adjustable Gastric Band (SAGB) in the treatment of morbid obesity over thw past 5 years. It is our intention to analyse follow-up data from those patients who have an SAGB.</interventions>
    <comparator>There is no control group for this series of patients</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Weight loss
Assessed by body mass index, body mass scales</outcome>
      <timepoint>Before and 12 months after surgery</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Complications of surgery e.g. post operative infection on clinical assessment</outcome>
      <timepoint>Before and 12 months after surgery</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Blood pressure measuerd using a sphygmomanometer</outcome>
      <timepoint>Before and 12 months after surgery</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Fasting blood lipids and glucose measured at a certified commercial laboratory</outcome>
      <timepoint>Before and 12 months after surgery</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Presence or absence of diabetes on clinical assessment</outcome>
      <timepoint>Before and 12 months after surgery</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Presence or absence of hypertension on clinical assessment</outcome>
      <timepoint>Before and 12 months after surgery</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>National Health &amp; Medical Research Council (NHMRC) criteria for surgery of body mass index (BMI) &gt;35 kg/m2 with one or more co-morbidities or BMI greater than 40 kg/m2</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Inability to understand follow-up and operative procedures, untreated psychiatric disorders and alcohol and/or drug abuse</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Natural history</purposeobs>
    <duration>Longitudinal</duration>
    <selection>Defined population</selection>
    <timing>Retrospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/01/2007</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>1200</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Ethicon Endo-Surgery</primarysponsorname>
    <primarysponsoraddress>Ethicon Endo-Surgery, Inc.
4545 Creek Road
Cincinnati, Ohio 45242</primarysponsoraddress>
    <primarysponsorcountry>United States of America</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Ethicon Endo-Surgery</fundingname>
      <fundingaddress>Ethicon Endo-Surgery, Inc.
4545 Creek Road
Cincinnati, Ohio 45242</fundingaddress>
      <fundingcountry>United States of America</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Bariatric surgery is increasingly used as a treatment for morbid obesity. This is a retrospective audit of existing data in which we wish to analyse the efficacy and safety of the Swedish Adjustable Gastric Band (SAGB) VC in the treatment of morbid obesity. It is our intention to analyse follow-up data from those patients who have an SAGB-VC.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Bellberry Ltd</ethicname>
      <ethicaddress>229 Greenhill Road
Dulwich  SA  5065</ethicaddress>
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate>20/01/2010</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Jennifer Keogh</name>
      <address>St Joseph's Cottage
Calvary Hospital 
89 Strangways Terrace
NORTH ADELAIDE SA 5006</address>
      <phone>+61 8 82671774</phone>
      <fax>+61 8 82673205</fax>
      <email>jennifer.keogh@internode.on.net</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Jennifer Keogh</name>
      <address>St Joseph's Cottage
Calvary Hospital 
89 Strangways Terrace
NORTH ADELAIDE SA 5006</address>
      <phone>+61 8 82671774</phone>
      <fax>+61 8 82673205</fax>
      <email>jennifer.keogh@internode.on.net</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Jennifer Keogh</name>
      <address>St Joseph's Cottage
Calvary Hospital 
89 Strangways Terrace
NORTH ADELAIDE SA 5006</address>
      <phone>+61 8 82671774</phone>
      <fax>+61 8 82673205</fax>
      <email>jennifer.keogh@internode.on.net</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>